Ablynx
  • EN
  • NL
  • A
  • A
  • A
Untitled Document
  • Home
  • About Ablynx
  • Research & development
  • Partnering
  • Careers
  • News & events
  • Investors
  • Contact
  • Press releases
  • Upcoming events
  • Past events & presentations
  • Press kit
Printer friendly
Home > News & events > Press releases

Press releases

2012

22/02/2012
ABLYNX ANNOUNCES 2011 FULL YEAR RESULTS


15/02/2012
ABLYNX WILL ANNOUNCE FULL YEAR RESULTS FOR 2011 WITH WEBCAST


14/02/2012
ABLYNX STRENGTHENS MANAGEMENT TEAM WITH THE APPOINTMENT OF DR ANDREAS MENRAD AS CHIEF SCIENTIFIC OFFICER


01/02/2012
ABLYNX RECEIVES ANOTHER MILESTONE AS BOEHRINGER INGELHEIM SELECTS NANOBODY CANDIDATE FOR PRE-CLINICAL DEVELOPMENT


22/01/2012
ABLYNX STATEMENT ON PRESS ARTICLE AND RELATED SHARE PRICE MOVEMENTS


19/01/2012
ABLYNX ANNOUNCES WARRANT EXERCISE


10/01/2012
ABLYNX IS GRANTED EXTENDED GMP CERTIFICATE FOR NEW GMP UNIT


09/01/2012
ABLYNX TO PRESENT PROGRESS IN 2011 AND ITS 2012 STRATEGY AT 30TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE


04/01/2012
ABLYNX ANNOUNCES WEBCAST OF ITS PRESENTATION AT THE 30TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE


Press releases

  • 2012

News archive

  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002

Email alerts

Click here if you would like to receive updates on the company news.

  • Glossary
  • Sitemap
  • Disclaimer
  • Contact Webmaster